The Cooper Companies, Inc. Third Quarter Earnings Sneak Peek

The Cooper Companies, Inc. (NYSE:COO) will unveil its latest earnings on Wednesday, August 31, 2011. Cooper Companies, Inc. develops, manufactures and markets healthcare products, primarily medical devices through its two business units, CooperVision, Inc. and CooperSurgical, Inc.

The Cooper Companies, Inc. Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average estimate of analysts is for net income of $1.08 per share, a rise of 18.7% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved up from $1.02. Between one and three months ago, the average estimate moved up, but it has been unchanged at $1.08 during the last month. For the year, analysts are projecting profit of $4.14 per share, a rise of 36.2% from last year.

Past Earnings Performance: The company has beaten estimates the last four quarters and is coming off a quarter where it topped forecasts by 9 cents, reporting net income of $1.02 per share against a mean estimate of profit of 93 cents per share.

Investing Insights: Steve Jobs Prepares to Deliver a New Catalyst for Apple’s Stock.

Wall St. Revenue Expectations: On average, analysts predict $331.8 million in revenue this quarter, a rise of 12.2% from the year ago quarter. Analysts are forecasting total revenue of $1.29 billion for the year, a rise of 11.2% from last year’s revenue of $1.16 billion.

Analyst Ratings: Analysts are bullish on this stock with six analysts rating it as a buy, none rating it as a sell and two rating it as a hold.

Key Stats:

The company has now seen net income rise in three straight quarters. In the second quarter, net income rose more than sevenfold while it rose more than twofold in the first quarter and 60% in the fourth quarter of the last fiscal year.

Revenue has risen the past four quarters. Revenue increased 12.5% to $325.3 million in second quarter. The figure rose 12.7% in the first quarter from the year earlier, climbed 10.5% in the fourth quarter of the last fiscal year from the year-ago quarter and 3.6% in the third quarter of the last fiscal year.

Competitors to Watch: STAAR Surgical Company (NASDAQ:STAA), Teleflex Incorporated (NYSE:TFX), Utah Medical Products, Inc. (NASDAQ:UTMD), Atrion Corporation (NASDAQ:ATRI), Covidien plc (NYSE:COV), Shamir Optical Industry Ltd. (NASDAQ:SHMR), Novartis AG (NYSE:NVS), C.R. Bard, Inc. (NYSE:BCR), Johnson & Johnson (NYSE:JNJ), and Boston Scientific Corp. (NYSE:BSX).

Stock Price Performance: During June 29, 2011 to August 25, 2011, the stock price had fallen $7.36 (-9.6%) from $76.74 to $69.38. The stock price saw one of its best stretches over the last year between January 28, 2011 and February 14, 2011 when shares rose for 12-straight days, rising 8.9% (+$5.07) over that span. It saw one of its worst periods between July 19, 2011 and July 28, 2011 when shares fell for eight-straight days, falling 5.6% (-$4.57) over that span. Shares are up $13.09 (+23.3%) year to date.

(Source: Xignite Financials)

Investing Insights: Steve Jobs Prepares to Deliver a New Catalyst for Apple’s Stock.